Lumature Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$95.2K Buy
825
+22
+3% +$2.5K 0.06% 194
2023
Q1
$85.4K Sell
803
-933
-54% -$101K 0.05% 194
2022
Q4
$193K Buy
1,736
+642
+59% +$65.6K 0.11% 152
2022
Q3
$94K Buy
1,094
+147
+16% +$13.1K 0.05% 197
2022
Q2
$86K Sell
947
-145
-13% -$12.9K 0.04% 210
2022
Q1
$90K Sell
1,092
-71
-6% -$5.6K 0.04% 220
2021
Q4
$89K Buy
1,163
+239
+26% +$19K 0.03% 194
2021
Q3
$69K Sell
924
-175
-16% -$13.3K 0.03% 211
2021
Q2
$85K Buy
1,099
+243
+28% +$18.1K 0.04% 189
2021
Q1
$63K Buy
+856
New +$63.1K 0.03% 210

Other funds holding MRK

Lumature Wealth Partners's MRK Position: Q2 2023 in Review

Lumature Wealth Partners increased its Merck (MRK) stake by 2.7% in Q2 2023, buying an estimated $2.5K and bringing the position to 825 shares worth $95.2K. The position accounts for 0.06% of the portfolio, ranked #194.

Lumature Wealth Partners first reported a position in MRK in Q1 2021 and has held it in 10 quarters since. The position peaked at $193K in Q4 2022. 3,256 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • Lumature Wealth Partners held 825 shares of Merck worth $95.2K as of Q2 2023.
  • Lumature Wealth Partners bought 22 Merck shares in Q2 2023, an estimated $2.5K.
  • Merck made up 0.06% of Lumature Wealth Partners's portfolio in Q2 2023, its #194 holding.
  • Lumature Wealth Partners first reported a position in Merck in Q1 2021 and has held it in 10 quarters since.
  • Lumature Wealth Partners's Merck position peaked at $193K in Q4 2022.
  • 3,256 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on Lumature Wealth Partners's 13F filing for Q2 2023, filed 14 Aug 2023.